Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Wexler

Showing results (301-310 of 418) with videos related to

Pageof 42
Sort By:
Bioorganic & Medicinal Chemistry Letters|March 5, 2018
Pyridazine and pyridazinone derivatives as potent and selective factor XIa inhibitorsZilun Hu, Cailan Wang, Wei Han, et al.
American Journal of Human Genetics|April 20, 2001
Recent origin and spread of a common Lithuanian mutation, G197del LDLR, causing familial hypercholesterolemia: positive selection is not always necessary to account for disease incidence among Ashkenazi JewsR Durst, R Colombo, S Shpitzen, et al.
Bioorganic & Medicinal Chemistry Letters|March 13, 2013
Discovery and gram-scale synthesis of BMS-593214, a potent, selective FVIIa inhibitorE Scott Priestley, Indawati De Lucca, Jinglan Zhou, et al.
Harefuah|March 2, 1980
[Surgical treatment of craniofacial dysostosis and hypertelorism]M R Wexler, I Peled, M Rousso, et al.
Bioorganic & Medicinal Chemistry Letters|April 29, 2014
2-Amino-1,3,4-thiadiazoles in the 7-hydroxy-N-neopentyl spiropiperidine indolinyl series as potent P2Y1 receptor antagonistsCarol H Hu, Jennifer X Qiao, Ying Han, et al.
Bioorganic & Medicinal Chemistry Letters|July 24, 2007
Enantiopure five-membered cyclicdiamine derivatives as potent and selective inhibitors of factor Xa. Improving in vitro metabolic stability via core modificationsJennifer X Qiao, Tammy C Wang, Gren Z Wang, et al.
Bioorganic & Medicinal Chemistry Letters|June 3, 2014
Design, synthesis and evaluation of phenethylaminoheterocycles as K(v)1.5 inhibitorsJames A Johnson, Ningning Xu, Yoon Jeon, et al.
ACS Medicinal Chemistry Letters|January 21, 2017
Design and Synthesis of Novel Meta-Linked Phenylglycine Macrocyclic FVIIa InhibitorsJeremy M Richter, Daniel L Cheney, J Alex Bates, et al.
Bioorganic & Medicinal Chemistry Letters|June 14, 2008
Achieving structural diversity using the perpendicular conformation of alpha-substituted phenylcyclopropanes to mimic the bioactive conformation of ortho-substituted biphenyl P4 moieties: discovery of novel, highly potent inhibitors of Factor XaJennifer X Qiao, Daniel L Cheney, Richard S Alexander, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2004
SAR and factor IXa crystal structure of a dual inhibitor of factors IXa and XaJoanne M Smallheer, Richard S Alexander, Jianmin Wang, et al.
Pageof 42

Showing results (301-310 of 418) with videos related to

Sort By:
Pageof 42
Bioorganic & Medicinal Chemistry Letters|March 5, 2018
Pyridazine and pyridazinone derivatives as potent and selective factor XIa inhibitorsZilun Hu, Cailan Wang, Wei Han, et al.
American Journal of Human Genetics|April 20, 2001
Recent origin and spread of a common Lithuanian mutation, G197del LDLR, causing familial hypercholesterolemia: positive selection is not always necessary to account for disease incidence among Ashkenazi JewsR Durst, R Colombo, S Shpitzen, et al.
Bioorganic & Medicinal Chemistry Letters|March 13, 2013
Discovery and gram-scale synthesis of BMS-593214, a potent, selective FVIIa inhibitorE Scott Priestley, Indawati De Lucca, Jinglan Zhou, et al.
Harefuah|March 2, 1980
[Surgical treatment of craniofacial dysostosis and hypertelorism]M R Wexler, I Peled, M Rousso, et al.
Bioorganic & Medicinal Chemistry Letters|April 29, 2014
2-Amino-1,3,4-thiadiazoles in the 7-hydroxy-N-neopentyl spiropiperidine indolinyl series as potent P2Y1 receptor antagonistsCarol H Hu, Jennifer X Qiao, Ying Han, et al.
Bioorganic & Medicinal Chemistry Letters|July 24, 2007
Enantiopure five-membered cyclicdiamine derivatives as potent and selective inhibitors of factor Xa. Improving in vitro metabolic stability via core modificationsJennifer X Qiao, Tammy C Wang, Gren Z Wang, et al.
Bioorganic & Medicinal Chemistry Letters|June 3, 2014
Design, synthesis and evaluation of phenethylaminoheterocycles as K(v)1.5 inhibitorsJames A Johnson, Ningning Xu, Yoon Jeon, et al.
ACS Medicinal Chemistry Letters|January 21, 2017
Design and Synthesis of Novel Meta-Linked Phenylglycine Macrocyclic FVIIa InhibitorsJeremy M Richter, Daniel L Cheney, J Alex Bates, et al.
Bioorganic & Medicinal Chemistry Letters|June 14, 2008
Achieving structural diversity using the perpendicular conformation of alpha-substituted phenylcyclopropanes to mimic the bioactive conformation of ortho-substituted biphenyl P4 moieties: discovery of novel, highly potent inhibitors of Factor XaJennifer X Qiao, Daniel L Cheney, Richard S Alexander, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2004
SAR and factor IXa crystal structure of a dual inhibitor of factors IXa and XaJoanne M Smallheer, Richard S Alexander, Jianmin Wang, et al.
Pageof 42